Testing procedures for gestational diabetes in pregnant women around the world need greater scrutiny to be reliable, researchers from The Australian National University (ANU) warn.
The researchers found a “significant flaw” in the approach commonly used that can lead to substantial underdiagnosis of the condition.
The problem arises if there is a delay in processing the glucose drink used to test patients’ blood samples. This is because the red and white blood cells continue to consume glucose. Delayed processing gives a false low glucose reading.
Lead researcher Professor Christopher Nolan, from the ANU Medical School, together with Professors Julia Potter and Peter Hickman from ACT Pathology, led a study of more than 12,000 women which found substantially higher rates of diagnosis when the blood samples were processed sooner.
Early centrifugation, within 10 minutes, compared to delayed centrifugation, increased the rate of diagnosis of gestational diabetes from 11.6 per cent to 20.6 per cent.
“This is a real problem leading to unreliable gestational diabetes test results in many countries around the world,” Professor Nolan said.
Gestational diabetes occurs during pregnancy and can lead to increased chance of abnormally larger baby birth weights, low blood glucose levels in the newborn and high blood pressure or pre-eclampsia in the mothers.
Mothers-to-be usually undergo screening between week 24 and 28 of pregnancy and between 12-14 per cent of women in Australia are found to develop it.
However, the ANU researchers say that number could be significantly higher if testing protocols were improved.
Current international guidelines for testing of gestational diabetes recommend the blood sample is placed in an ice slurry and centrifuged – where the blood sample is spun to separate the cells – within 30 minutes of collection. However, this guideline is difficult to implement, particularly if the blood collection site is distant to the laboratory, like it commonly is for rural women.
Professor Nolan said an easy fix would be to change the chemicals in the blood test collection tubes from sodium fluoride to citrate.
Sodium fluoride is used to slow down the consumption of glucose by the blood cells, but according to Professor Nolan it does a very poor job.
Citrate in the tubes, however, is much better in that it immediately stops glucose consumption, making the ice slurry and strict timing of blood processing unnecessary. The citrate stabilises the glucose in the blood sample.
Professor Nolan says his research highlights the importance of the preanalytical processing protocol and urges that more research is needed before adopting citrate tubes widely.
In the meantime, Professor Nolan strongly encourages pregnant women to continue having glucose tolerance tests in pregnancy, as the current approach does diagnose women with gestational diabetes who are the most in need of treatment.
The research is published here: https://care.diabetesjournals.org/content/43/7/1438.
Trisha Toangwera Aruhuri was a long way from home when she received the diagnosis that would change her life. The support of the ANU community has been crucial to her recovery.
New ANU technology could help predict a person's risk of developing Alzheimer's disease up to 20 years before symptoms show.
A first-of-its-kind study looking at the levels of pain experienced by cancer survivors provides evidence on when pain is most likely to be experienced.